PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,601,378 | -22.2% | 4,622,920 | +23.9% | 0.00% | -25.0% |
| Q2 2023 | $49,619,302 | -51.0% | 3,730,775 | -57.3% | 0.00% | -20.0% |
| Q1 2023 | $101,166,748 | +8107.7% | 8,736,334 | +5697.8% | 0.01% | – |
| Q4 2022 | $1,232,590 | +12.8% | 150,683 | -20.0% | 0.00% | – |
| Q3 2022 | $1,093,000 | -79.7% | 188,300 | -84.6% | 0.00% | -100.0% |
| Q2 2022 | $5,395,000 | -59.9% | 1,220,723 | -17.5% | 0.00% | 0.0% |
| Q1 2022 | $13,463,000 | -63.3% | 1,479,433 | -17.5% | 0.00% | -66.7% |
| Q4 2021 | $36,670,000 | +444.8% | 1,792,291 | +580.4% | 0.00% | +200.0% |
| Q3 2021 | $6,731,000 | -26.9% | 263,411 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,209,000 | -90.7% | 263,338 | -91.2% | 0.00% | -87.5% |
| Q1 2021 | $99,136,000 | +1982620.0% | 2,976,162 | +1653323.3% | 0.01% | – |
| Q4 2020 | $5,000 | +400.0% | 180 | +252.9% | 0.00% | – |
| Q3 2020 | $1,000 | -99.8% | 51 | -99.9% | 0.00% | – |
| Q4 2014 | $470,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |